125 related articles for article (PubMed ID: 9568110)
21. Combination of mutated herpes simplex virus type 1 (G207 virus) with radiation for the treatment of squamous cell carcinoma of the head and neck.
Kim SH; Wong RJ; Kooby DA; Carew JF; Adusumilli PS; Patel SG; Shah JP; Fong Y
Eur J Cancer; 2005 Jan; 41(2):313-22. PubMed ID: 15661558
[TBL] [Abstract][Full Text] [Related]
22. Mechanism(s) of antitumor action in protracted infusion of low dose 5-fluorouracil and cisplatin in gastric carcinoma.
Kim R; Tanabe K; Inoue H; Toge T
Int J Oncol; 2002 Mar; 20(3):549-55. PubMed ID: 11836567
[TBL] [Abstract][Full Text] [Related]
23. The evaluation of gastric cancer sensitivity to 5-FU/CDDP in terms of induction of apoptosis: time- and p53 expression-dependency of anti-cancer drugs.
Matsuhashi N; Saio M; Matsuo A; Sugiyama Y; Saji S
Oncol Rep; 2005 Sep; 14(3):609-15. PubMed ID: 16077963
[TBL] [Abstract][Full Text] [Related]
24. [Sensitivity test of anticancer agents using human tumor xenografts in nude mice with special reference on correlation between clinical effects and chemotherapy].
Nosoh Y; Yoshinaka K; Nishimawari K; Hirono M; Tani T; Niimoto M; Hattori T
Gan No Rinsho; 1984 Jul; 30(9 Suppl):1181-5. PubMed ID: 6433069
[TBL] [Abstract][Full Text] [Related]
25. Enhanced radiosensitization of p53 mutant cells by oleamide.
Lee YJ; Chung DY; Lee SJ; Ja Jhon G; Lee YS
Int J Radiat Oncol Biol Phys; 2006 Apr; 64(5):1466-74. PubMed ID: 16580498
[TBL] [Abstract][Full Text] [Related]
26. Radiosensitivity of human breast cancer cells transduced with wild-type p53 gene is influenced by the p53 status of parental cells.
Maeda T; Matsubara H; Koide Y; Sugaya M; Miyazawa Y; Tasaki K; Isono K; Ochiai T; Sakiyama S; Tagawa M
Anticancer Res; 2000; 20(2A):869-74. PubMed ID: 10810368
[TBL] [Abstract][Full Text] [Related]
27. Activation of p53 protein in normal and in tumor cells by a novel anticancer agent CHS 828.
Wojciechowski J; Lövborg H; Wesierska-Gadek J
Drugs Exp Clin Res; 2003; 29(2):53-67. PubMed ID: 12951835
[TBL] [Abstract][Full Text] [Related]
28. Efficacy with a replication-selective adenovirus plus cisplatin-based chemotherapy: dependence on sequencing but not p53 functional status or route of administration.
Heise C; Lemmon M; Kirn D
Clin Cancer Res; 2000 Dec; 6(12):4908-14. PubMed ID: 11156251
[TBL] [Abstract][Full Text] [Related]
29. Silibinin strongly synergizes human prostate carcinoma DU145 cells to doxorubicin-induced growth Inhibition, G2-M arrest, and apoptosis.
Tyagi AK; Singh RP; Agarwal C; Chan DC; Agarwal R
Clin Cancer Res; 2002 Nov; 8(11):3512-9. PubMed ID: 12429642
[TBL] [Abstract][Full Text] [Related]
30. (E)-2'-deoxy-2'-(fluoromethylene) cytidine potentiates radioresponse of two human solid tumor xenografts.
Sun LQ; Li YX; Guillou L; Coucke PA
Cancer Res; 1998 Dec; 58(23):5411-7. PubMed ID: 9850073
[TBL] [Abstract][Full Text] [Related]
31. Effect of 3,4-dihydro-6-[4-(3,4-dimethoxybenzoyl)-1-piperazinyl]-2(1H)- quinolinone (vesnarinone) on the growth of gastric cancer cell lines.
Yokozaki H; Ito R; Ono S; Hayashi K; Tahara E
Cancer Lett; 1999 Jun; 140(1-2):121-8. PubMed ID: 10403550
[TBL] [Abstract][Full Text] [Related]
32. [Anticancer activities of a new mitomycin derivative KW 2149, against human tumors xenografted into nude mice].
Nishiyama M; Kim R; Saeki T; Takagami S; Kirihara Y; Jinushi K; Toge T; Niimoto M; Hattori T
Gan To Kagaku Ryoho; 1988 Nov; 15(11):3133-7. PubMed ID: 3142368
[TBL] [Abstract][Full Text] [Related]
33. A quinolinone derivative, vesnarinone (OPC-8212), significantly inhibits the in vitro and in vivo growth of human pancreatic cancer cell lines.
Nio Y; Ohmori H; Minari Y; Hirahara N; Sasaki S; Takamura M; Tamura K
Anticancer Drugs; 1997 Aug; 8(7):686-95. PubMed ID: 9311445
[TBL] [Abstract][Full Text] [Related]
34. Effects of quinolinone derivative, vesnarinone, in combination with irradiation on human lung cancer cell lines.
Fujita M; Tsuchida T; Fujita T; Higashino K
Oncol Rep; 1999; 6(2):353-7. PubMed ID: 10023004
[TBL] [Abstract][Full Text] [Related]
35. Utilization of nude mice in research on human cancer--screening system of anticancer agents using human tumor xenografts in nude mice.
Ueyama Y
Prog Clin Biol Res; 1987; 229():287-310. PubMed ID: 3601990
[TBL] [Abstract][Full Text] [Related]
36. Induction of differentiation and enhancement of vincristine sensitivity of human erythroleukemia HEL cells by vesnarinone, a positive inotropic agent.
Sato S; Tomoyasu S; Okabe-Kado J; Hozumi M; Tsuruoka N; Nakai S; Adachi M; Honma Y
Exp Hematol; 1996 Jan; 24(1):37-42. PubMed ID: 8536790
[TBL] [Abstract][Full Text] [Related]
37. Synergistic anticancer effect of rAd/P53 combined with 5-fluorouracil or iodized oil in the early therapeutic response of human colon cancer in vivo.
Xie Q; Liang BL; Wu YH; Zhang J; Chen MW; Liu HY; Gu XF; Xu J
Gene; 2012 May; 499(2):303-8. PubMed ID: 22441128
[TBL] [Abstract][Full Text] [Related]
38. [Experimental chemotherapy of human gastrointestinal and breast cancers in nude mice and its correlation to clinical effect].
Fujita M; Fujita F; Taguchi T
Gan No Rinsho; 1984 Jul; 30(9 Suppl):1168-74. PubMed ID: 6433068
[TBL] [Abstract][Full Text] [Related]
39. Treatment of virus-induced myocardial injury with a novel immunomodulating agent, vesnarinone. Suppression of natural killer cell activity and tumor necrosis factor-alpha production.
Matsui S; Matsumori A; Matoba Y; Uchida A; Sasayama S
J Clin Invest; 1994 Sep; 94(3):1212-7. PubMed ID: 8083362
[TBL] [Abstract][Full Text] [Related]
40. The combined antitumour effect of a new 5-fluorouracil derivative, BOF-A2, and radiation in vivo.
Murata R; Shibamoto Y; Miyauchi S; Hirohashi M; Takagi T; Sasai K; Oya N; Hiraoka M
Br J Cancer Suppl; 1996 Jul; 27():S114-6. PubMed ID: 8763861
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]